Protein therapy involves giving enough of the functional protein, usually recombinant (laboratory manufactured), which is missing or faulty in people with EB. This could be given via local injections, via microneedles or delivered systemically via the intravenous route. Future research may also include investigating topical and ocular applications.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.